- ►prsjournal.com [PDF] HF Fine - British Medical Journal, 2007 - bjo.bmj.com With new, highly effective therapies such as ranibizumab 1, 2 (Lucentis),
bevacizumab 3 (Avastin) and many promising treatments on the horizon for
choroidal neovascularisation (CNV) due to age-related macular degeneration ... Cited by 2 - Related articles - BL Direct - All 4 versions
S Honda, H Imai, K Yamashiro, Y Kurimoto, N … - Ophthalmologica, 2009 - content.karger.com Purpose: We aimed to evaluate the effects of photodynamic therapy (PDT) on
different phenotypes of age-related macular degenerations (AMD): typical AMD
(tAMD) and polypoidal choroidal vasculopathy (PCV). Procedures: 246 eyes ... Related articles - All 4 versions
TA Ciulla - Expert Review of Ophthalmology, 2007 - ingentaconnect.com Vision loss due to age-related macular degeneration (AMD) is a major public
health issue that significantly impacts the quality of life of affected
individuals and their families. Recently approved anti-VEGF agents have ... Related articles - BL Direct - All 3 versions
C Policy, G Background, AR Devices - cigna.com The following Coverage Policy applies to all plans administered by CIGNA
Companies including plans administered by Great-West Healthcare, which is now a
part of CIGNA. ... Effective Date ............................ 1/15/2009 ... Related articles - View as HTML - All 8 versions